Additionally, HIST1H2BK correlates with metastatic CRC cytokine secretion, myeloid leukocyte migration into the tumour, and resistance to proteasome-inhibitor-based anticancer therapy [59]. Here, H2BC12 is linked to colorectal carcinoma.